The Translational Mixer
Two lapsed Nature editors, Andy Marshall and Juan-Carlos Lopez, have a conversation and a cocktail with experts in translational research and biomedicine
Episodes
12 episodes
Episode 12: CHDI's Robert Pacifici on new treatments for Huntington's toasted with a Boulevardier
Andy and JC get the lowdown from Robert Pacifici, CSO of CHDI Foundation, on the latest in Huntington's treatments from the recent 20th CHDI Therapeutics Conference in Palm Springs, California. Robert has spearheaded efforts at CHDI for the pas...
•
Season 2
•
Episode 3
•
58:57
Episode 11: William Pao on the hunt for life-changing drugs and a refreshing Hugo spritz
William Pao, CEO of Revelio Therapeutics, and former Chief Development Officer for Pfizer/Head of Roche pRED, sits down with JC and Andy to talk about his new book: '
•
Season 2
•
Episode 2
•
53:54
Episode 10: Sebastian Giwa blazing a trail in organ storage/transplantation ...and a flaming Sambuca
Sebastian Giwa, co-founder of the Organ Preservation Alliance and the Biostasis Research Institute and serial entrepreneur, talks to JC and An...
•
Season 2
•
Episode 10
•
53:33
Episode 9: Charles Fracchia on cyberattacks in biology...and downloading an Aperol Spritz
Andy and JC explore the murky world of cyberthreats to biopharma and biomanufacturing with Charles Fracchia, CEO of a Boston startup Black Mesa, currently in stealth mode and co-founder of BIO-ISAC, a BIO-Information Sharing and Analysis Center...
•
54:42
Episode 8: Andrew Lo on fixing business models in biotech and a sparkling Mio sake!
https://bit.ly/3YxRltJ. Andrew Lo, Charles E. & Susan T. Harris Professor of Finance and director of the Laboratory for Financial Engineering at the MIT Sloan School of Management, gives JC and Andy the skinny on his progress in finding new...
•
Season 1
•
Episode 8
•
55:59
Episode 7: Anne Wyllie, COVID-19, the NBA and spit diagnostics washed down with a G&T!
Anne Wyllie, principal investigator at the Yale School of Public Health and pioneer of the Saliva Direct initiative, talks to JC and Andy about the potential of open and collaborative models to transform infectious disease diagnostics and pande...
•
Season 1
•
Episode 7
•
57:45
Episode 6: Veronique Kiermer on open science and a White Negroni
Veronique Kiermer, Chief Scientific Officer and Executive Editor at the Public Library of Science, talks about the myriad ways in which open science is changing the face of research and some...
•
Season 1
•
Episode 6
•
51:00
Episode 5: Nathan Price on scientific wellness and a Mojito
Nathan Price, currently on leave from the Institute for Systems Biology in Seattle and Chief Scientific Officer at Thorne HealthTech, talks to JC and Andy about his data-driven approach to understanding health and predicting personal trajectori...
•
Season 1
•
Episode 5
•
49:34
Episode 4: Dan Kaufman on off-the-shelf cell therapy and Manhattans
UCSD's Dan Kaufman, an innovator in the field of induced pluripotent cell (iPSC)-derived natural killer cell therapies, talks to Andy and JC about the latest in allogeneic and autologous immune and regenerative cell therapies at the 2024 ...
•
44:08
Episode 3: Kiran Musunuru, gene and base editors hit the clinic and a Bloody Mary mix
UPenn's Kiran Musunuru, a human geneticist and practicing cardiologist who has pioneered the translation of gene- and base-editing approaches, talks to JC and Andy about the latest clinical results and modalities discussed at the 2024 Key...
•
Season 1
•
Episode 3
•
49:48
Episode 2: Eric Topol, multimodal AI models in medicine, and a glass of Merlot
Scripps' Eric Topol is a visionary in the application of artificial intelligence to medicine. He has a wide-ranging conversation with JC and Andy about : 02:52 Multimodal AI is coming06:44 FDA-approved AI software10:02...
•
Season 1
•
Episode 2
•
41:53
